GT200300239A - BENZOFURAN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROFILAXIS OF VIRAL INFECTIONS OF HEPATITIS C AND ASSOCIATED DISEASES - Google Patents

BENZOFURAN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROFILAXIS OF VIRAL INFECTIONS OF HEPATITIS C AND ASSOCIATED DISEASES

Info

Publication number
GT200300239A
GT200300239A GT200300239A GT200300239A GT200300239A GT 200300239 A GT200300239 A GT 200300239A GT 200300239 A GT200300239 A GT 200300239A GT 200300239 A GT200300239 A GT 200300239A GT 200300239 A GT200300239 A GT 200300239A
Authority
GT
Guatemala
Prior art keywords
profilaxis
hepatitis
treatment
viral infections
compositions
Prior art date
Application number
GT200300239A
Other languages
Spanish (es)
Inventor
Ashis K Saha
Christopher J Burns
Alfred M Del Vecchio
Thomas R Bailey
Bheemashankar A Kulkarni
Thomas H Faitg
Susan R Sherk
Charles W Blackledge
David J Rys
Thomas A Lessen
John Swestock
Yijun Deng
Theodore J Nitz
Jason A Reinhardt
Hao Feng
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200300239A publication Critical patent/GT200300239A/en

Links

Abstract

LA PRESENTE INVENCION SE REFIERE AL COMPUESTO DE FORMULA GENERAL I EN LA QUE R1,R2,R3,R4,R5,R6, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON DE UTILIDAD PARA EL TRATAMIENTO O PROFILAXIS DE INFECCIONES VIRALES, PARTICULARMENTE AQUELLAS ASOCIADAS Y CAUSADAS POR EL VIRUS DE LA HEPATITIS C.THIS INVENTION REFERS TO THE COMPOUND OF GENERAL FORMULA I IN WHICH R1, R2, R3, R4, R5, R6, ARE FUNCTIONAL GROUPS DESCRIBED IN THE RECORD. THESE COMPOUNDS ARE USEFUL FOR THE TREATMENT OR PROFILAXIS OF VIRAL INFECTIONS, PARTICULARLY THOSE ASSOCIATED AND CAUSED BY THE VIRUS OF HEPATITIS C.

GT200300239A 2002-11-01 2003-11-03 BENZOFURAN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROFILAXIS OF VIRAL INFECTIONS OF HEPATITIS C AND ASSOCIATED DISEASES GT200300239A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42329102P 2002-11-01 2002-11-01

Publications (1)

Publication Number Publication Date
GT200300239A true GT200300239A (en) 2004-06-23

Family

ID=44839295

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200300239A GT200300239A (en) 2002-11-01 2003-11-03 BENZOFURAN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROFILAXIS OF VIRAL INFECTIONS OF HEPATITIS C AND ASSOCIATED DISEASES

Country Status (2)

Country Link
CR (1) CR7831A (en)
GT (1) GT200300239A (en)

Also Published As

Publication number Publication date
CR7831A (en) 2005-10-05

Similar Documents

Publication Publication Date Title
BR0305426A (en) Hsv ns5b polymerase inhibitor compounds as well as pharmaceutical composition comprising the same
ECSP055801A (en) BENZOFURANIC COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROFILAXIS OF HEPATITIS C VIRAL INFECTIONS AND ASSOCIATED DISEASES
CR8935A (en) INHIBITORS OF THE RNA POLYMERASE DEPENDENT ON THE RNA OF THE HEPATITIS C VIRUS AND COMPOSITIONS
BR0305259A (en) Hcv ns5b polymerase inhibitors
BRPI0415883A (en) nucleoside compounds and compositions for the treatment of viral infections
GT200600339A (en) MACROCICLIC INHIBITORS OF HEPATITIS C VIRUS
CL2004001161A1 (en) COMPOUNDS DESCRIBES COMPOUNDS DERIVED FROM QUINOLINA; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT AN ILLNESS CAUSED BY THE HEPATITIS C VIRUS.
UY28084A1 (en) NUCLEOSID ANTIVIRAL DERIVATIVES
EA200500584A1 (en) NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY THE HEPATITIS C VIRUS
BRPI0416902A (en) hepatitis c virus ns3 / ns4a serine protease inhibitors
GT200600262A (en) USE OF SANGLIFERINE IN HCV (HEPATITIS VIRUS "C")
UY29266A1 (en) PIRIDAZINONA COMPOUNDS
EA200800371A1 (en) HCV Protease Inhibitors
CU23787B7 (en) MACROCYCLIC COMPOUNDS AS INHIBITORS OF VIRAL REPLICATION
ECSP066858A (en) GSK-3 INHIBITORS
GT200400161A (en) REPLACED PYRIDINONES
MY164469A (en) Hcv ns3 protease inhibitors
EA200802346A1 (en) CYCLOPROPILCONDENATED INDOBOBENZEZEPINOVA INHIBITORS OF HELPATITIS VIRUS NS5B PROTEIN
EA200701849A1 (en) TRUNCTIONAL COMPOUNDS OF TRICYCLIC NUCLEOSIDES, PHARMACEUTICAL COMPOSITION ON THEIR BASIS AND METHOD OF TREATMENT AND / OR INHIBITION OF VIRAL INFECTION IN THE MAMMALIAN
UY30778A1 (en) COMPOUNDS OF 5,6-DIHIDRO-1H-PIRIDIN-2-ONA
UY28582A1 (en) METHODS TO PREPARE DERIVATIVES 7- (B (BETA) -D-RIBOFURANOSIL REPLACED IN 2ยด) -4 (NR2R3) -5- (ETIN-1-ILO REPLACED) -PIRROL (2,3-D) PYRIMIDINE
GT200500292A (en) DERIVATIVES OF 2-AMIDO-4-FENILTIAZOL, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
WO2005084315A3 (en) Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease
GT200500308A (en) NONADEPSIPEPTIDES ACILATED II
GT200300275A (en) ANTIVIRAL NUCLEOSIDE DERIVATIVES